Forxiga receives positive EU CHMP for type I diabetes in adults

4th February 2019 Uncategorised 0

AstraZeneca’s Forxiga has been recommended by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) as an oral adjunct treatment to insulin in adults with type I diabetes.

More: Forxiga receives positive EU CHMP for type I diabetes in adults
Source: News